|Bid||65.00 x 200|
|Ask||69.75 x 100|
|Day's range||65.24 - 65.99|
|52-week range||46.86 - 66.11|
|PE ratio (TTM)||37.28|
|Earnings date||2 Nov 2017|
|Forward Dividend & Yield||0.42 (0.65%)|
|1y target est||67.41|
Zoetis Inc. will participate in the Credit Suisse Healthcare Conference on Tuesday, Nov. 7, 2017, in Scottsdale, Ariz. Executive Vice President and Chief Financial Officer Glenn David, will represent the company and respond to questions from analysts.
The Board of Directors of Zoetis Inc. has declared a fourth quarter 2017 dividend payable to holders of the company’s common stock of $0.105 per share. The dividend is to be paid on Friday, Dec.
Anatara Lifesciences (ASX:ANR) is pleased to announce that global animal health company, Zoetis Inc. (‘Zoetis’) has exercised its option to negotiate a commercial agreement for the worldwide development, distribution and marketing of Detach®, with terms to be agreed.
PARSIPPANY, N.J--(BUSINESSWIRE)-- Acquisition strengthens pipeline of companion animal therapeutics for chronic pain, a global market estimated at US$400 million annually 1 Purchase price of US$6.72 per ...
PARSIPPANY, N.J. & TULLAMORE, Ireland--(BUSINESSWIRE)-- Acquisition strengthens pipeline of companion animal therapeutics for chronic pain, a global market estimated at US$400 million annually 1 Purchase ...
Jim Cramer spoke with Juan Ramon Alaix, the CEO of animal health giant Zoetis, to get the latest on pet treatments.
U.S. stock indexes were little changed on Thursday as a steep fall for the energy sector countered some solid earnings reports, with Wall Street remaining flat after the U.S. House of Representatives passed major healthcare legislation. The House on Thursday afternoon narrowly voted to repeal major portions of the 2010 Affordable Care Act, known as Obamacare, and replace it with a Republican healthcare plan, sending it to the Senate for consideration. The bill's passage comes after House Republicans pulled healthcare legislation earlier this year in a setback, raising questions among investors about President Donald Trump's ability to enact his agenda.
ZAVENTEM, Belgium--(BUSINESSWIRE)-- The first monoclonal antibody authorized for veterinary use in the European Union A single injection of Cytopoint treats the clinical signs of atopic dermatitis in dogs, ...
Zoetis Inc. (NYSE:ZTS) and Nexvet Biopharma plc (Nasdaq:NVET) today announced an agreement in which Zoetis, through a wholly owned subsidiary (“Zoetis Bidco”), will purchase Nexvet, an innovator in monoclonal antibody therapies for companion animals, for a purchase price of US$6.72 per share, representing an aggregate equity valuation of approximately US$85 million. The acquisition will strengthen Zoetis’ pipeline of solutions for chronic pain management in dogs and cats, which represents an area of high-need in companion animal health.
PARSIPPANY, N.J. & TULLAMORE, Ireland--(BUSINESSWIRE)-- Purchase price of US$6.72 per share, or approximately US$85 million in aggregate Acquisition to strengthen Zoetis’ pipeline in companion animal therapeutics ...
PARSIPPANY, N.J.--(BUSINESSWIRE)-- A new topical parasiticide for cats combines the active ingredient in Stronghold – selamectin – with sarolaner for broadened and extended spectrum of protection Company ...
Jim Cramer reviews the monster bid for VCA from Mars, but warns that the space isn't created equal.